Transitioning from intramuscular (IM) to oral aripiprazole in patients with schizophrenia

被引：0
|
作者：
Daniel, D. [1 ]
Crandall, D. [1 ]
Manos, G. [1 ]
McQuade, R. [1 ]
机构：
[1] Bioniche Dev Inc, United BioSource Inc, Mclean, VA USA
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：426 / 427
页数：2
相关论文
共 50 条
  • [21] EFFECTIVENESS OF SWITCHING FROM ARIPIPRAZOLE TO ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA
    Yoon, Jin-Sang
    Kim, Sung-Wan
    Shin, I. S.
    Kim, J. M.
    Yoo, J. A.
    Bae, K. Y.
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 327 - 327
  • [22] Clinical impact of aripiprazole in patients suffering from schizophrenia
    Levoyer, D.
    Drapier, D.
    Fadier-Salice, G.
    Millet, B.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2007, 33 (03): : 332 - 338
  • [23] Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia
    Yoon, J. -S.
    Lee, J. -H.
    Kim, S. -W.
    Yang, S. -J.
    Jang, J. -E.
    Kim, J. -M.
    Shin, I. -S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 246 - 247
  • [24] Effectiveness of Switching From Aripiprazole to Ziprasidone in Patients With Schizophrenia
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Bae, Kyung-Yeol
    Yang, Su-Jin
    Yoon, Jin-Sang
    CLINICAL NEUROPHARMACOLOGY, 2010, 33 (03) : 121 - 125
  • [25] EFFECTIVENESS OF SWITCHING FROM ARIPIPRAZOLE TO ZIPRASIDONE IN PATIENTS WITH SCHIZOPHRENIA
    Kim, Sung-Wan
    Shin, Il-Seon
    Kim, Jae-Min
    Bae, Kyung-Yeol
    Yang, Su-Jin
    Yoon, Jin-Sang
    SCHIZOPHRENIA RESEARCH, 2010, 117 (2-3) : 379 - 379
  • [26] Efficacy of intramuscular aripiprazole in the management of agitated patients
    De Filippis, S.
    Cuomo, I.
    De Persis, S.
    Parisi, M.
    Di Pasquale, C.
    De Vecchis, L.
    Penna, L.
    Sciarretta, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S272 - S273
  • [27] Intramuscular aripiprazole for the treatment of agitation in schizophrenia and bipolar disorder: from clinical research to clinical practice
    Fagiolini, A.
    De Filippis, S.
    Azzarelli, O.
    Boidi, G.
    Lang, A. Padovan
    Rocchetti, G.
    Villari, V.
    Bellomo, A.
    JOURNAL OF PSYCHOPATHOLOGY-GIORNALE DI PSICOPATOLOGIA, 2013, 19 (01): : 34 - 41
  • [28] Intramuscular versus oral aripiprazole in the management of acute patients, with and without substance abuse: a natural study
    Fini, C.
    Motta, P.
    Zingaretti, P.
    Porrari, R.
    De Persis, S.
    De Filippis, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 : S502 - S502
  • [29] The effectiveness of a single intramuscular injection of aripiprazole in patients with schizophrenia or bipolar disorder, stratified by levels of agitation at baseline
    Zimbroff, D.
    Vester-Blokland, E.
    Manos, G.
    Auby, P.
    Pikalov, A.
    Oren, D. A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S276 - S276
  • [30] A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia
    Battaglia, J
    Houston, JP
    Ahl, J
    Meyers, AL
    Kaiser, CJ
    CLINICAL THERAPEUTICS, 2005, 27 (10) : 1612 - 1618
12345